INSM

2025Q4BMO

Insmed Inc primary · HEALTHCARE · BIOTECHNOLOGY

Report 2026-02-19 · Fiscal end 2025-12-31 · Features as of 2026-02-18

← Earnings history

Pre-Earnings Data

Expectations & setup

Street

Consensus EPS-1.17
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—

Options

Implied move6.8%
IV front—
P/C full—
P/C front—
Features as of2026-02-18

Run-up

Close—
Ret 5d+1.7%
Ret 10d-3.8%
Ret 20d-7.6%
Ret 30d-13.7%

Post-Earnings Data

Results & reaction

Print

Actual EPS
-1.54Miss
Estimated EPS-1.17
Actual revenue
263.8M
Surprise %-31.6%
Beat / missMiss
Beat streak 40
Beat streak 80

Reaction

1-day stock reaction+4.7%
Implied vs actual

Implied 6.8%Actual 1.8%

Gap reaction+1.8%
Day result+6.5%
Next-day upYes
Realized / IV0.26×

Post tape

Post 5d-6.8%
Post 10d-10.8%
Post volume4.9M
Vol ×10d2.36×
Vol ×20d2.22×
Post range10.3%